Abstract
目的： 分析柱状细胞型甲状腺乳头状癌（columnar cell variant of papillary thyroid carcinoma，CCV-PTC）的临床病理特征及预后，并着重探讨甲状腺癌常见驱动基因突变状态。 方法： 回顾性分析7例CCV-PTC的临床资料及组织学形态，EnVision法进行免疫表型分析，突变阻滞扩增系统（ARMS）-PCR检测BRAF V600E基因突变，Sanger测序检测RAS及端粒酶逆转录酶基因（TERT）启动子基因突变。 结果： 男性4例，女性3例，年龄29~65岁。组织学肿瘤细胞呈柱状、假复层排列，7例均表达甲状腺滤泡上皮标记，1例表达CDX2，p53均呈野生型表达。4例存在BRAF V600E突变（4/7），4例存在TERT启动子突变（4/5），5例均未见RAS突变（0/5）。术后随访8~89个月，4例出现肿瘤复发，2例死亡。 结论： CCV-PTC以柱状肿瘤细胞假复层排列为特征，可表达CDX2，具有较高的BRAF V600E及TERT启动子突变率，浸润性生长者预后较差。.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhonghua bing li xue za zhi = Chinese journal of pathology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
